126
Views
0
CrossRef citations to date
0
Altmetric
Case Report

External-Beam Radiotherapy Alone Management of Primary CNS Lymphoplasmacytic Lymphoma: A Vietnamese Case Report and Literature Review

ORCID Icon, , , &
Pages 769-774 | Published online: 21 Aug 2021

References

  • Naderi N, Yang DT. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia. Arch Pathol Lab Med. 2013;137(4):580–585. doi:10.5858/arpa.2012-0034-RS
  • Marzia Varettoni, Emanuela Boveri, Silvia Zibellini, et al. Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. Am J Hematol. 2019;94(11):1193-1199. doi: 10.1002/ajh.25600
  • Iwanaga M, Chiang C-J, Soda M, et al. Incidence of lymphoplasmacytic lymphoma/Waldenström’s macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996–2003. Int J Cancer. 2014;134(1):174–180. doi:10.1002/ijc.28343
  • Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International agency for research on cancer; 2008.
  • Jahnke K, Korfel A, O’Neill BP, et al. International study on low-grade primary central nervous system lymphoma. Ann Neurol. 2006;59(5):755–762. doi:10.1002/ana.20804
  • Bogdahn U, Bogdahn S, Mertens HG, et al. Primary non-Hodgkin’s lymphomas of the CNS. Acta Neurol Scand. 1986;73(6):602–614. doi:10.1111/j.1600-0404.1986.tb04607.x
  • Shenkier TN. Unusual variants of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005;19(4):651–664. doi:10.1016/j.hoc.2005.05.001
  • Abbi KKS, Muzaffar M, Gaudin D, et al. Primary CNS lymphoplasmacytic lymphoma: a case report and review of literature. Hematol Oncol Stem Cell Ther. 2013;6(2):76–78. doi:10.1016/j.hemonc.2013.06.002
  • Yan C, Kong X, Yang L, et al. An uncommon case of lymphoplasmacytic lymphoma in cerebellopontine angle region. Medicine (Baltimore). 2016;95(34):e4627. doi:10.1097/MD.0000000000004627
  • Layden BT, Dubner S, Toft DJ, et al. Primary CNS lymphoma with bilateral symmetric hypothalamic lesions presenting with panhypopituitarism and diabetes insipidus. Pituitary. 2011;14(2):194–197. doi:10.1007/s11102-008-0166-7
  • Ikeda T, Hara K, Yamanaka T, et al. [A case of primary central nervous system malignant lymphoma developing from the optic chiasma and hypothalamus]. Rinsho Shinkeigaku. 2006;46(7):475–479. Japanese.
  • Lim T, Kim SJ, Kim K, et al. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes. Ann Hematol. 2011;90(12):1391–1398. doi:10.1007/s00277-011-1225-0
  • Braks E, Urbach H, Pels H, et al. Primary central nervous system immunocytoma: MRI and spectroscopy. Neuroradiology. 2000;42:738–741. doi:10.1007/s002340000392
  • Carrasco CA, Rojas ZD, Chiorino R, et al. Primary pituitary lymphoma in immunocompetent patient: diagnostic problems and prolonged follow-up. Pituitary. 2012;15(1):93–96. doi:10.1007/s11102-010-0219-6
  • Kanavaros P, Mikol J, Nemeth J, et al. Stereotactic biopsy diagnosis of primary non-Hodgkin’s lymphoma of the central nervous system: a histological and immunohistochemical study. Pathol Res Pract. 1990;186(4):459–466. doi:10.1016/S0344-0338(11)80464-4
  • Fintelmann F, Forghani R, Schaefer PW, et al. Bing-Neel syndrome revisited. Clin Lymphoma Myeloma. 2009;9(1):104–106. doi:10.3816/CLM.2009.n.028
  • Minnema MC, Kimby E, D’Sa S. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica. 2017;102(1):43–51. doi:10.3324/haematol.2016.147728
  • Grainger BT, Issa S. Bing-Neel syndrome presenting as isolated CNS lymphoplasmacytic lymphoma: a case report and review of the literature. J Clin Neurosci. 2019;71:277–280.
  • Henry JM, Heffner RR, Dillard SH, et al. Primary malignant lymphomas of the central nervous system. Cancer. 1974;34(4):1293–1302. doi:10.1002/1097-0142(197410)34:4<1293::AID-CNCR2820340441>3.0.CO;2-P
  • Kwak Y-K, Choi B-O, Choi KH, et al. Radiotherapy as an alternative treatment option for primary central nervous system lymphoma patients who are noncandidates for chemotherapy. Oncotarget. 2017;8(63):106858–106865. doi:10.18632/oncotarget.22427
  • Kazda T, Pospíšil P, Doleželová H, et al. Whole brain radiotherapy: consequences for personalized medicine. Rep Pract Oncol Radiother. 2013;18(3):133–138. doi:10.1016/j.rpor.2013.03.002